Who we are

Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. We are a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.

Our Purpose and Ambition

Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. That is our purpose. 

Our business ambition is to be the world’s leading and most valued generics company.

For more information, please visit https://www.sandoz.com/